Related Experiment Video
Updated: Feb 28, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Tuberculosis Treatment Completion in a United States/Mexico Binational Context
Celina I Valencia1, Kacey Ernst2, Cecilia Ballesteros Rosales3
1Department of Community, Environment, and Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
Tuberculosis treatment completion is higher for females and those without drug use or HIV. Migration and deportation were key barriers to completing treatment along the U.S./Mexico border.
Area of Science:
- Public Health
- Infectious Diseases
- Border Health
Background:
- Tuberculosis (TB) poses a significant public health challenge in the U.S./Mexico border region.
- Understanding social and structural factors influencing TB disease burden is crucial.
- Identifying treatment completion barriers informs culturally relevant interventions.
Purpose of the Study:
- To identify social and structural factors associated with TB disease burden.
- To determine barriers to TB treatment completion in the binational region.
- To inform evidence-based, context-specific interventions for the U.S./Mexico border.
Main Methods:
- Retrospective study of 439 TB patients' medical charts from Yuma County Health Department and Centro de Salud San Luis Río Colorado.
- Exclusion of patients currently undergoing TB treatment.
- Statistical analysis including chi-square, odds ratios, and logistic regression to identify predictors of successful TB treatment.
Main Results:
- Females demonstrated a higher likelihood of completing TB treatment (OR=3.71).
- Absence of drug use and/or HIV diagnosis predicted treatment completion.
- Migration or deportation was the most frequent reason for incomplete treatment (20.78%).
Conclusions:
- Social and structural factors, particularly migration and deportation, significantly impact TB treatment completion.
- Targeted interventions addressing these barriers are needed for the U.S./Mexico border population.
- Public health strategies should consider gender, substance use, and HIV status in TB management.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Affecting Factors

